Table. Description of Studies Included in Systematic Review.
| Study characteristics | Studies, No. (%) (N = 89) |
|---|---|
| Publication year | |
| 2000-2010 | 21 (24) |
| 2011-2023 | 68 (76) |
| Study design | |
| Cohort study | 88 (99) |
| Post hoc analysis randomized trial | 1 (1) |
| Continent | |
| Europe | 36 (40) |
| Asia | 24 (27) |
| North America | 20 (22) |
| Oceania | 5 (6) |
| South America | 1 (1) |
| Africa | 1 (1) |
| Multiple | 2 (2) |
| No. of hospitals included | |
| 1 | 44 (49) |
| 2-20 | 33 (37) |
| >20 | 13 (15) |
| No. of patients included | |
| 200-1000 | 69 (78) |
| 1000-10 000 | 15 (17) |
| >10 000 | 4 (4) |
| Population | |
| All SAB patients | 82 (92) |
| Health care/hospital-associated SAB | 3 (3) |
| Community-acquired SAB | 4 (4) |
| Outcome measure | |
| 7-d mortality | 1 (1) |
| 14-d mortality | 4 (4) |
| 28-30–d mortality | 54 (61) |
| 90-d mortality | 9 (10) |
| In-hospital mortality | 16 (18) |
| Attributable mortality | 5 (6) |
| MRSA vs MSSA | |
| Both MRSA and MSSA | 59 (66) |
| Only MRSA | 20 (22) |
| Only MSSA | 10 (11) |
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; SAB, Staphylococcus aureus bacteremia.